AI assistant
REGENXBIO Inc. — Director's Dealing 2018
Jun 19, 2018
32827_dirs_2018-06-19_cdecb8bd-8451-48e2-a188-3791a9f710b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENXBIO Inc. (RGNX)
CIK: 0001590877
Period of Report: 2018-06-15
Reporting Person: Vasista Vittal (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-15 | Common Stock | S | 3157.00 | $56.20 | Disposed | 141626.00 | Direct |
| 2018-06-15 | Common Stock | S | 4343.00 | $56.90 | Disposed | 137283.00 | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades at prices ranging from $55.70 to $56.675. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices ranging from $56.70 to $57.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.